✦ LIBER ✦

Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

✍ Scribed by Pritchard, Kathleen I.; Burris, Howard A.; Ito, Yoshinori; Rugo, Hope S.; Dakhil, Shaker; Hortobagyi, Gabriel N.; Campone, Mario; Csöszi, Tibor; Baselga, José; Puttawibul, Puttisak; Piccart, Martine; Heng, Daniel; Noguchi, Shinzaburo; Srimuninnimit, Vichien; Bourgeois, Hugues; Gonzalez Martin, Antonio; Osborne, Karen; Panneerselvam, Ashok; Taran, Tetiana; Sahmoud, Tarek; Gnant, Michael

Book ID: 121408476
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 782 KB
Volume: 13
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2013.08.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of everolimus with exemestane v

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2

✍ Noguchi, Shinzaburo; Masuda, Norikazu; Iwata, Hiroji; Mukai, Hirofumi; Horiguchi 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 662 KB

Everolimus in Combination with Exemestan

Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB

NICE guidance on everolimus in combinati

NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapy

✍ Burke, Martyn J; Garrett, Zoe; George, Elisabeth; Adler, Amanda I 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 53 KB

P308 Optimal duration of neoadjuvant exe

P308 Optimal duration of neoadjuvant exemestane treatment in elderly women with estrogen receptor-positive/HER2-negative breast cancer

✍ H. Takei; T. Saito; Y. Ishikawa; Y. Hayashi; M. Kurosumi; T. Kai; T. Tabei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

BOLERO-2: Everolimus in combination with

BOLERO-2: Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive ADVANCED breast cancer refractory to letrozole or anastrozole

✍ Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

PO59 EFFICACY AND SAFETY OF EVEROLIMUS P

PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6

✍ de Boer, Richard; Jerusalem, Guy; Hurvitz, Sara; Ejlertsen, Bent; El-Hashimy, Mo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB